Register now for the European Congress on Osteoporosis & Osteoarthritis in Bordeaux

December 06, 2011

Don't miss out on low early bird rates for the premier bone meeting in 2012. The European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12), from March 21-24, 2012 will be held in in the magnificent city of Bordeaux, France. Take advantage of low early bird rates: register by December 9, 2011 at http://www.iof-ecceo12.org

Enjoy a high quality programme led by international experts and key thought leaders...

Plenary lectures:

  • The conundrum of biological ageing - L. Partridge (Servier Honorary lecture)
  • Changes in epidemiology of osteoporotic fractures - C. Cooper
  • Gender specificity, the male paradigm - E. Orwoll
  • How bone is built - E. Seeman (Educational lecture)
  • Is Rheumatoid Arthritis a bone disease? - W.F. Lems
  • Current controversies in primary and secondary fracture prevention - E. McCloskey
  • How long should we treat - C. Roux
  • Risk-benefits of osteoporosis treatment: lessons from cohort or randomized controlled studies - B. Abrahamsen
  • FRAX: where are we now? - J. Kanis
  • Building new bone: is that possible? - S. Papapoulos

  • Meet-the-expert sessions:

  • Efficacy and safety of calcium supplements - S. Boonen
  • Management of osteoarthritis - T. Bardin
  • Sequential therapies - S. Ferrari
  • Sarcopenia and frailty: assessment and management (2 sessions) - A.A. Sayer & Y. Rolland
  • Clinical utility of bone turnover markers - J.C. Souberbielle
  • Avascular necrosis - T. Thomas
  • Obesity and fracture risk - J. Compston
  • Bone disease in primary hyperparathyroidism - J.P. Bilezikian
  • Nutrition and bone - B. Dawson-Hughes
  • Prevalent fracture and quality of life - J. Adachi
  • Whole body vibration - E. McCloskey • and more...

  • Special symposia:

  • ESCEO-FIRMO Symposium - Prevention of bone fractures in post-menopausal women treated with aromatase inhibitors for breast cancer
  • ESCEO-FROMO-IOF Symposia
  • - Treatment of glucocorticoïd-induced osteoporosis (GIOP) - Treatment of osteoporosis in men - Tools to assess frailty and sarcopenia - Antidepressant medications and osteoporosis
  • ESCEO Symposium
  • - Diagnosis and treatment of osteoarthritis: state of the art
  • ESCEO-FROMO Symposium
  • - How to define responders in osteoarthritis?
  • GREES-ESCEO Symposium
  • - Health Claims for Nutriceuticals Products in the Field of Cartilage and Joint
  • ESCEO-ISPOR Symposium
  • - Compliance with osteoporosis medications: Causes of poor adherence; current statuts, clinical and economical consequences and interventions
  • GRIO-SFR Session
  • - Scientific Session jointly organized by the "Groupe de Recherche et d'Information sur les Ostéoporoses" (GRIO) and the "Société Française de Rhumatologie" (SFR)

    The program also includes seven informative Satellite Symposia, as well as oral and poster presentations. Several prestigious awards, including for young investigators, will be presented. Further information is available on the meeting website at http://www.iof-ecceo12.org

    Interested in translational bone research?
    The 2nd IOF-ESCEO Pre-Clinical Symposium, will be held from March 23-24, 2012 in conjunction with IOF-ECCEO12. This two-day forum dedicated to basic and translational bone research is free to registrants of IOF-ECCEO12 (or only 150 euro for access to Symposium alone). The Symposium is chaired by Stuart Ralston.

    Submit your abstract:
    Ensure your research is showcased at this internationally renowned congress. All abstracts will be published in 'Osteoporosis International'.
    Abstract Deadline: January 12, 2012

    Complete programme information is available at http://www.iof-ecceo12.org
    -end-
    Key Dates
    Early-Bird: December 9, 2011
    Abstract Deadline: January 12, 2012
    Pre-Registration online: March 7, 2012

    International Osteoporosis Foundation

    Related Osteoporosis Articles from Brightsurf:

    New opportunities for detecting osteoporosis
    Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

    Oxytocin can help prevent osteoporosis
    In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

    New strategy against osteoporosis
    An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

    New review on management of osteoporosis in premenopausal women
    An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

    Cardiac CT can double as osteoporosis test
    Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

    Osteoporosis treatment may also protect against pneumonia
    A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

    New pharmaceutical target reverses osteoporosis in mice
    Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

    A link between mitochondrial damage and osteoporosis
    In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

    Many stroke patients not screened for osteoporosis, despite known risks
    Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

    Many postmenopausal women do not receive treatment for osteoporosis
    The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

    Read More: Osteoporosis News and Osteoporosis Current Events
    Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.